Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arcutis Biotherapeutics (ARQT) Asset Utilization Ratio (2022 - 2025)

Historic Asset Utilization Ratio for Arcutis Biotherapeutics (ARQT) over the last 4 years, with Q3 2025 value amounting to 0.88.

  • Arcutis Biotherapeutics' Asset Utilization Ratio rose 17949.13% to 0.88 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.88, marking a year-over-year increase of 17949.13%. This contributed to the annual value of 0.57 for FY2024, which is 27768.93% up from last year.
  • Latest data reveals that Arcutis Biotherapeutics reported Asset Utilization Ratio of 0.88 as of Q3 2025, which was up 17949.13% from 0.76 recorded in Q2 2025.
  • Over the past 5 years, Arcutis Biotherapeutics' Asset Utilization Ratio peaked at 0.88 during Q3 2025, and registered a low of 0.0 during Q3 2022.
  • For the 4-year period, Arcutis Biotherapeutics' Asset Utilization Ratio averaged around 0.3, with its median value being 0.24 (2024).
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first surged by 734658.29% in 2023, then soared by 13574.02% in 2024.
  • Quarter analysis of 4 years shows Arcutis Biotherapeutics' Asset Utilization Ratio stood at 0.01 in 2022, then skyrocketed by 2010.41% to 0.16 in 2023, then skyrocketed by 207.91% to 0.5 in 2024, then surged by 75.81% to 0.88 in 2025.
  • Its Asset Utilization Ratio stands at 0.88 for Q3 2025, versus 0.76 for Q2 2025 and 0.61 for Q1 2025.